This is not the most recent version of the article. View current version (18 JAN 2012)

Intervention Protocol

Myeloablative high-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults

  1. Markus Schaaf1,*,
  2. Nicole Skoetz1,
  3. Ina Monsef1,
  4. Corinne Brillant1,
  5. Marcel Reiser2,
  6. Andreas Engert1

Editorial Group: Cochrane Haematological Malignancies Group

Published Online: 15 APR 2009

DOI: 10.1002/14651858.CD007678


How to Cite

Schaaf M, Skoetz N, Monsef I, Brillant C, Reiser M, Engert A. Myeloablative high-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD007678. DOI: 10.1002/14651858.CD007678.

Author Information

  1. 1

    University Hospital of Cologne, Cochrane Haematological Malignancies Group, Department I of Internal Medicine, Cologne, Germany

  2. 2

    University Hospital of Cologne, Department I of Internal Medicine, Center of Integrated Oncology Köln Bonn, Cologne, Germany

*Markus Schaaf, Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Kerpener Str. 62, Cologne, 50924, Germany. markus.schaaf@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 15 APR 2009

SEARCH

This is not the most recent version of the article. View current version (18 JAN 2012)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To compare the efficacy of myeloablative high-dose chemotherapy with autologous stem cell transplantation to chemotherapy or immuno-chemotherapy in first-line or relapsed follicular lymphoma.